newsfilter
← Latest News
GlobeNewswire·

ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders

  • ENvue Medical, Inc. (NASDAQ: FEED) resumed commercial shipments of PainShield®, manufactured in the United States, & fulfilled open orders from exclusive U.S. distributor Ultra Pain Products, Inc.
  • The resumption of shipments follows the transfer of NanoVibronix manufacturing operations from Israel to the United States to restore supply continuity & streamline operations.
  • Research & development for the NanoVibronix product portfolio, which includes PainShield®, remains based in Tel Aviv, Israel.
  • PainShield® is a wearable, non-invasive therapeutic ultrasound device designed for pain treatment & available by prescription in the U.S.
  • ENvue Medical focuses on two technology platforms: the ENvue™ Navigation Platform for real-time guided feeding tube placement & acoustic-based therapeutic technologies utilizing surface acoustic wave technology.
  • The Company provided forward-looking statements regarding anticipated operational efficiencies, supply continuity, & commercial growth, while noting risks such as market acceptance, competition, & regulatory changes.
  • Investor & media contacts for ENvue Medical are listed as KCSA Strategic Communications representatives Valter Pinto & Michaela Fawcett.